Tobin, Rachel
Patel, Nidhi
Tobb, Kardie
Weber, Brittany
Mehta, Puja K.
Isiadinso, Ijeoma
Article History
Accepted: 6 September 2023
First Online: 28 September 2023
Declarations
:
: Brittany Weber reports personal fees for the Scientific Advisory Board from Novo Nordisk, Kiniksa, and Novo Nordisk. Ijeoma Isiadinso serves as the site principal investigator on the Novartis-sponsored HORIZON study, but does not personally receive any funds, and their institution receives payment for services provided by study coordinators from Novartis Pharmaceuticals. In addition, Dr. Isiadinso receives consulting fees from Novartis Pharmaceuticals. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.